BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37146655)

  • 1. High-mobility group box 1 (HMGB1) crosses the BBB bidirectionally.
    Banks WA; Hansen KM; Erickson MA; Crews FT
    Brain Behav Immun; 2023 Jul; 111():386-394. PubMed ID: 37146655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mobility group box-1 (HMGB1) antagonist BoxA suppresses status epilepticus-induced neuroinflammatory responses associated with Toll-like receptor 2/4 down-regulation in rats.
    Yu S; Zhang H; Hei Y; Yi X; Baskys A; Liu W; Long Q
    Brain Res; 2019 Aug; 1717():44-51. PubMed ID: 30986405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaempferol alleviates LPS-induced neuroinflammation and BBB dysfunction in mice via inhibiting HMGB1 release and down-regulating TLR4/MyD88 pathway.
    Cheng X; Yang YL; Yang H; Wang YH; Du GH
    Int Immunopharmacol; 2018 Mar; 56():29-35. PubMed ID: 29328946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence.
    Crews FT; Qin L; Sheedy D; Vetreno RP; Zou J
    Biol Psychiatry; 2013 Apr; 73(7):602-12. PubMed ID: 23206318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor.
    Hreggvidsdóttir HS; Lundberg AM; Aveberger AC; Klevenvall L; Andersson U; Harris HE
    Mol Med; 2012 Mar; 18(1):224-30. PubMed ID: 22076468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
    Good DW; George T; Watts BA
    Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaempferol Attenuates LPS-Induced Striatum Injury in Mice Involving Anti-Neuroinflammation, Maintaining BBB Integrity, and Down-Regulating the HMGB1/TLR4 Pathway.
    Yang YL; Cheng X; Li WH; Liu M; Wang YH; Du GH
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.
    Wang FC; Pei JX; Zhu J; Zhou NJ; Liu DS; Xiong HF; Liu XQ; Lin DJ; Xie Y
    World J Gastroenterol; 2015 Jul; 21(25):7764-76. PubMed ID: 26167076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased receptor for advanced glycation end product expression in the human alcoholic prefrontal cortex is linked to adolescent drinking.
    Vetreno RP; Qin L; Crews FT
    Neurobiol Dis; 2013 Nov; 59():52-62. PubMed ID: 23867237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Mobility Group Box-1 and Blood-Brain Barrier Disruption.
    Nishibori M; Wang D; Ousaka D; Wake H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33321691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.
    Mazarati A; Maroso M; Iori V; Vezzani A; Carli M
    Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroacupuncture Improves Blood-Brain Barrier and Hippocampal Neuroinflammation in SAMP8 Mice by Inhibiting HMGB1/TLR4 and RAGE/NADPH Signaling Pathways.
    Wang Y; Wang Q; Luo D; Zhao P; Zhong SS; Dai B; Wang JJ; Wan YT; Liu ZB; Yang H
    Chin J Integr Med; 2023 May; 29(5):448-458. PubMed ID: 36609953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products.
    Chen Y; Huang XJ; Yu N; Xie Y; Zhang K; Wen F; Liu H; Di Q
    PLoS One; 2015; 10(10):e0140918. PubMed ID: 26485677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
    Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
    PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytokine mRNA increase induced by withdrawal from chronic ethanol in the sterile environment of brain is mediated by CRF and HMGB1 release.
    Whitman BA; Knapp DJ; Werner DF; Crews FT; Breese GR
    Alcohol Clin Exp Res; 2013 Dec; 37(12):2086-97. PubMed ID: 23895427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-high mobility group box-1 antibody therapy for traumatic brain injury.
    Okuma Y; Liu K; Wake H; Zhang J; Maruo T; Date I; Yoshino T; Ohtsuka A; Otani N; Tomura S; Shima K; Yamamoto Y; Yamamoto H; Takahashi HK; Mori S; Nishibori M
    Ann Neurol; 2012 Sep; 72(3):373-84. PubMed ID: 22915134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of neuronal HMGB1 by ethanol through decreased HDAC activity activates brain neuroimmune signaling.
    Zou JY; Crews FT
    PLoS One; 2014; 9(2):e87915. PubMed ID: 24551070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.
    Cai J; Yuan H; Wang Q; Yang H; Al-Abed Y; Hua Z; Wang J; Chen D; Wu J; Lu B; Pribis JP; Jiang W; Yang K; Hackam DJ; Tracey KJ; Billiar TR; Chen AF
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2579-93. PubMed ID: 26515416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of a role for spinal HMGB1 in ischemic stress-induced mechanical allodynia in mice.
    Matsuura W; Harada S; Liu K; Nishibori M; Tokuyama S
    Brain Res; 2018 May; 1687():1-10. PubMed ID: 29476751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
    Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.